Finance

Lists
XLO:NASDAQ
Xilio Therapeutics Inc
7,56 $
-1,11%
(-0,085) 1D
20 қар., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XLO...
Open
7,43 $
High
7,60 $
Low
7,06 $
Mkt. cap
53,40 млн
Avg. vol.
13,48 мың
Volume
20,10 мың
52-wk high
11,20 $
52-wk low
6,47 $
EPS
-0,26 $
Beta
-0,11
Shares outstanding
7,06 млн
No. of employees
76
Open
7,43 $
High
7,60 $
Low
7,06 $
Mkt. cap
53,40 млн
Avg. vol.
13,48 мың
Volume
20,10 мың
52-wk high
11,20 $
52-wk low
6,47 $
EPS
-0,26 $
Beta
-0,11
Shares outstanding
7,06 млн
No. of employees
76
News stories
From web sources and news partners
About Xilio Therapeutics Inc
CEO-
Employees76
Founded2016
HeadquartersWaltham, Массачусетс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Frahm
TD Cowen
Buy
Maintained
-
-
11/13/2025
Last report
2026 ж. 10 қар.
Fiscal period
Q3 2026
-0,30 $ / -1,68 $
+82,14%beat
Revenue / Est. (USD)
9,98 млн / 4,92 млн
+102,93%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
13,69 млн
12,65 млн
18,69 млн
9,98 млн
Cost of goods sold
-37,92 млн
19,83 млн
14,56 млн
14,80 млн
Cost of revenue
-37,92 млн
19,83 млн
14,56 млн
14,80 млн
Research and development expenses
56,04 млн
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,40 млн
6,93 млн
7,62 млн
6,93 млн
Operating expense
63,44 млн
6,93 млн
7,62 млн
6,93 млн
Total operating expenses
25,52 млн
26,76 млн
22,18 млн
21,73 млн
Operating income
-11,84 млн
-14,11 млн
-3,49 млн
-11,75 млн
Other non operating income
24,70 млн
3,30 млн
-2,88 млн
4,82 млн
EBT including unusual items
10,36 млн
-9,53 млн
-6,37 млн
-5,95 млн
EBT excluding unusual items
10,36 млн
-9,53 млн
-6,37 млн
-5,95 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
10,36 млн
-9,53 млн
-6,37 млн
-5,95 млн
Net profit margin
75,70%
-75,34%
-34,09%
-59,58%
Earnings per share
-
-
-
-
Interest and investment income
-
1,28 млн
-
981,00 м.
Interest expense
-2,50 млн
-
-
-
Net interest expenses
-2,50 млн
1,28 млн
-
981,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,51 млн
-13,77 млн
-3,16 млн
-11,43 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары